| Size | Price | |
|---|---|---|
| Other Sizes |
| Targets |
Amino acid derivative; valine analog
H-D-Val-OMe.HCl is classified as a D-amino acid derivative and valine analogue. It does not have a specific biological receptor target. Its primary application is as a building block in peptide synthesis for introducing D-valine residues with C-terminal methyl ester protection. The D-configuration provides stereochemical control for producing single-stereoisomer peptides with enhanced proteolytic stability. |
|---|---|
| ln Vitro |
Commercial ergot supplements have been made from amino acids and their derivatives. They affect the release of anabolic hormones, the availability of fuel for activity, the ability to think clearly under pressure, and the prevention of muscular damage brought on by exertion. They are regarded as advantageous synergistic food ingredients [1].
In vitro activity for H-D-Val-OMe.HCl is primarily as a peptide synthesis reagent. D-Valine has exhibited inhibitory effects on fibroblasts that contaminated mammalian kidney cultures, allowing for selective growth of epithelial cells. H-D-Val-OMe.HCl itself is not directly biologically active; its utility is in preparing D-valine-containing peptides for subsequent biological evaluation. |
| ln Vivo |
In vivo activity data for H-D-Val-OMe.HCl as a standalone compound is not applicable. It is a protected D-amino acid ester used as a research building block and is not intended for direct in vivo administration. Peptides synthesized using this building block may be evaluated in animal models for various biological activities. The methyl ester is typically hydrolyzed before biological testing.
|
| Enzyme Assay |
In vitro SPPS protocols for H-D-Val-OMe.HCl involve standard peptide synthesis chemistry. The compound is activated with coupling reagents and coupled to a growing peptide chain. The methyl ester can be hydrolyzed under basic conditions. Purity is typically >98.0%.
|
| Cell Assay |
Cell-based protocols are not directly applicable to H-D-Val-OMe.HCl as it is a protected amino acid derivative. D-Valine-containing peptides synthesized using this reagent can be tested in cell culture after deprotection. Peptides are dissolved in DMSO or appropriate buffers and added to cells at concentrations of 0.1-100 µM for 24-72 hours.
|
| Animal Protocol |
Animal studies with H-D-Val-OMe.HCl are not conducted directly. Peptides containing D-valine residues synthesized using this building block may be evaluated in vivo. Protocols involve administration of the peptide via appropriate routes in animal models. Pharmacokinetic sampling, efficacy assessment, and toxicological evaluation follow standard preclinical study designs.
|
| ADME/Pharmacokinetics |
Pharmacokinetic data for H-D-Val-OMe.HCl as a standalone compound is not applicable. The compound has a molecular weight of 167.63 g/mol, formula C6H14ClNO2, and CAS number 7146-15-8. Storage is recommended at room temperature (below 15°C).
|
| Toxicity/Toxicokinetics |
Limited toxicological data is available for H-D-Val-OMe.HCl. The compound is for research use only and is not intended for human therapeutic use. Standard safety precautions for handling laboratory chemicals should be observed. No specific toxicity studies have been reported.
|
| References | |
| Additional Infomation |
Nutritional enhancers have long been used to improve athletic and competitive performance. A wide variety of dietary ingredients with enhancing effects are widely used by athletes. However, these ingredients are frequently subject to legal scrutiny due to their claimed benefits and safety concerns. Amino acid derivatives are widely touted as adjuvants that can effectively enhance physical and mental performance in multiple ways, but research suggests that individuals with amino acid deficiencies are more likely to benefit from amino acid derivative supplements than those with normal deficiencies. This article reviews some of the most common and widely used amino acid derivatives in sports and competitive sports, including creatine, tyrosine, carnitine, HMB, and taurine, and explores their effects on athletic performance, mental activity, and physical strength and composition. Creatine, carnitine, HMB, and taurine have been reported to delay the onset of fatigue and improve athletic performance and physical strength. HMB helps increase lean body mass and reduce exercise-induced muscle damage. Taurine has been found to reduce oxidative stress during exercise and has a blood pressure-lowering effect. While studies have not yet found any beneficial effects of tyrosine on athletic performance, it has been shown to effectively combat stress and improve mood and cognitive function, especially in individuals with sleep deprivation. Although published research data and results are still inconclusive regarding the efficacy of creatine, tyrosine, and HMB, more comprehensive research is needed on carnitine and taurine to provide a theoretical basis for their synergistic effects in nutritional adjustment and supplementation. [1]
H-D-Val-OMe.HCl (CAS#: 7146-15-8) is also known as D-valine methyl ester hydrochloride and methyl (2R)-2-amino-3-methylbutanoate;hydrochloride. Its molecular formula is C6H14ClNO2. It is a D-amino acid derivative used in peptide synthesis. It has no approved therapeutic indications. |
| Molecular Formula |
C6H14CLNO2
|
|---|---|
| Molecular Weight |
167.63386
|
| Exact Mass |
167.071
|
| CAS # |
7146-15-8
|
| PubChem CID |
11984198
|
| Appearance |
White to off-white powder
|
| Boiling Point |
145.7ºC at 760 mmHg
|
| Melting Point |
~170 °C (dec.)
|
| Flash Point |
20.7ºC
|
| Index of Refraction |
-15 ° (C=2, H2O)
|
| LogP |
1.645
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
3
|
| Heavy Atom Count |
10
|
| Complexity |
101
|
| Defined Atom Stereocenter Count |
1
|
| SMILES |
CC(C)[C@H](C(=O)OC)N.Cl
|
| InChi Key |
KUGLDBMQKZTXPW-NUBCRITNSA-N
|
| InChi Code |
InChI=1S/C6H13NO2.ClH/c1-4(2)5(7)6(8)9-3;/h4-5H,7H2,1-3H3;1H/t5-;/m1./s1
|
| Chemical Name |
methyl (2R)-2-amino-3-methylbutanoate;hydrochloride
|
| Synonyms |
Methyl (R)-2-amino-3-methylbutanoate hydrochloride; H-D-Val-OMe.HCl; O-Methyl-D-valine hydrochloride; 7146-15-8; D-Valine methyl ester hydrochloride; H-D-Val-OMe.HCl; Methyl D-valinate hydrochloride; 21685-47-2; (R)-Methyl 2-amino-3-methylbutanoate hydrochloride; O-Methyl-D-valine (hydrochloride); MFCD00237309; Methyl D-valinate hydrochloride; NSC 22921
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O : ≥ 100 mg/mL (~596.55 mM)
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 5.9655 mL | 29.8276 mL | 59.6552 mL | |
| 5 mM | 1.1931 mL | 5.9655 mL | 11.9310 mL | |
| 10 mM | 0.5966 mL | 2.9828 mL | 5.9655 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
